Related Experiment Video
Updated: Aug 8, 2026

Murine Model of CD40-activation of B cells
Published on: March 6, 2010
Activation signals leading to proliferation of normal and leukemic CD3+ large granular lymphocytes
J A Aprile1, M Russo, M S Pepe
1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98104.
Insights
Normal and leukemic CD3+ large granular lymphocytes (LGL) proliferate in vitro. Activation signals including anti-CD3 monoclonal antibody and interleukin-2 directly stimulate leukemic LGL proliferation.
Area of Science:
- Immunology
- Hematology
- Cell Biology
Background:
- CD3+ large granular lymphocytes (LGL) are involved in immune responses.
- Understanding the proliferation signals of normal and leukemic LGL is crucial for therapeutic strategies.
Purpose of the Study:
- To investigate the in vitro activation signals that induce proliferation of normal and leukemic CD3+ LGL.
- To determine the role of T-cell receptor and lymphokine signaling in LGL proliferation.
Main Methods:
- Peripheral blood mononuclear cells (PBMC) from LGL leukemia patients were cultured with anti-CD3 monoclonal antibody (MoAb) and/or recombinant interleukin-2 (IL-2) or interleukin-4 (IL-4).
- Proliferation was measured using a 3H-thymidine incorporation assay.
- Purified leukemic LGL were assessed for cell cycle entry (S + G2/M phase) using Hoechst staining after activation.
Main Results:
- Both anti-CD3 MoAb and IL-2 alone significantly stimulated PBMC proliferation (P < .01).
- Recombinant IL-4 alone had no significant effect (P = .11).
- Combined anti-CD3 MoAb with IL-2 or IL-4 resulted in greater proliferation than either stimulus alone (P < .01).
- Purified leukemic LGL showed direct stimulation by anti-CD3 MoAb and IL-2, with 16%-72% entering the cell cycle.
- Normal CD3+ LGL also entered the cell cycle upon stimulation with anti-CD3 and IL-2.
Conclusions:
- Leukemic LGL proliferate in vitro upon activation through the T-cell receptor and/or lymphokine signaling pathways.
- Anti-CD3 MoAb and IL-2 are potent stimulators of both normal and leukemic CD3+ LGL proliferation.
- These findings highlight the potential for targeting these pathways in LGL leukemia treatment.
Abstract:
The activation signals leading to proliferation of normal and leukemic CD3+ large granular lymphocytes (LGL) were studied in vitro. Anti-CD3 monoclonal antibody (MoAb) alone (P less than .01) and recombinant interleukin-2 (IL-2) alone (P less than .01) caused significant stimulation of peripheral blood mononuclear cells (PBMC) from four CD3+ LGL leukemia patients, as measured in a 3H-thymidine incorporation assay. Recombinant interleukin-4 (IL-4) alone had no effect (P = .11). The combination signals of anti-CD3 MoAb and either IL-2 or IL-4 produced a proliferative response greater than anti-CD3 MoAb alone (P less than .01) or lymphokine alone (P less than .01). Leukemic LGL, purified by two-color sorting, were subsequently activated by anti-CD3 MoAb and IL-2 and assessed for DNA content by viable Hoechst No. 33342 (HO) staining. Results of these studies demonstrated that leukemic LGL were stimulated directly by anti-CD3 MoAb and IL-2, with the percentage of cells in cell cycle (S + G2/M) ranging from 16% to 72%. Normal CD3+ LGL were also stimulated to enter the cell cycle by anti-CD3 and IL-2. These results show that leukemic LGL proliferate in vitro after activation through the T-cell receptor and/or lymphokine.
Related Concept Videos
Mitogens and the Cell Cycle
Differentiation of Common Myeloid Progenitor Cells
Cells of the Adaptive Immune Response
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

